Proviron 25mg/tab 50 Tabletten by Nassa Labs

Usage

1. Step 1 — Identify your clearance date: note the date of your final AAS injection and the half-life of the longest ester used. Multiply that half-life by five to determine your earliest safe PCT start date.
2. Step 2 — Run a pre-PCT blood panel: test LH, FSH, total testosterone, and SHBG on or just before your calculated clearance date. Confirm LH and FSH are above 1.0 IU/L before introducing mesterolone.
3. Step 3 — Begin mesterolone and SERM on the same day: start both agents simultaneously on the confirmed clearance date. Take Nassa Labs Proviron with a meal to support absorption — mesterolone is lipophilic and benefits from dietary fat co-ingestion.
4. Step 4 — Dose at the same time each day: consistent daily timing maintains stable plasma concentrations. Morning dosing alongside breakfast fits most users and aligns with natural diurnal testosterone peaks.
5. Step 5 — Schedule a mid-PCT blood panel at week 3–4: measure LH, FSH, free testosterone, and total testosterone. Results guide whether to maintain the current dose, step down early, or extend the protocol by one to two weeks.
6. Step 6 — End the protocol at confirmed recovery: discontinue mesterolone when total testosterone is sustained above 400 ng/dL across two consecutive weekly readings and LH is within the normal reference range. Retain lot documentation (batch number, HPLC report reference) for your own records.

Warnings

Frequently asked questions

How do I calculate the exact date to start PCT with mesterolone after my last injection?

Count five half-lives from your final injection of the longest-acting ester in the cycle. Testosterone enanthate has a half-life of approximately 7 days, so its five-half-life clearance point falls around day 35 post-injection. Testosterone propionate clears in roughly 10 days. Begin mesterolone and your SERM on that calculated clearance date — this is when residual exogenous suppression has dropped to approximately 3 % of peak concentration.

What happens if you introduce mesterolone into PCT before exogenous androgens have fully cleared?

Starting mesterolone before the exogenous suppression window has closed means adding peripheral androgenic load to a system whose HPG axis is still suppressed. The SHBG-binding benefit of mesterolone is most productive once endogenous testosterone is actively being produced in response to recovering LH pulses. Premature introduction does not accelerate HPG restart and may marginally prolong the suppression timeline by contributing androgenic feedback.

Which blood test values confirm the PCT start window is open and it is safe to begin mesterolone?

A pre-PCT panel should show LH and FSH above 1.0 IU/L, confirming that pituitary gonadotropin output has resumed following the removal of exogenous suppression. Total testosterone below the lower reference range (typically below 300 ng/dL) alongside detectable LH indicates the HPG axis is reactivating but output is not yet restored — the ideal entry point for mesterolone and SERM co-administration.

Does the 25 mg per tablet strength of Nassa Labs Proviron offer any practical advantage for timing-based PCT dosing?

Yes. At 25 mg per tablet, each Nassa Labs Proviron tablet equals the standard clinical unit dose, so daily scheduling aligns to whole tablets rather than fractions. This is directly relevant to timing-based protocols where the start date, dose escalation points, and taper decisions are tied to calendar-mapped blood-panel results — whole-tablet increments reduce the arithmetic and handling errors that splitting introduces.

How long does the 50-tablet pack of Nassa Labs Proviron last at typical PCT dosing, and is one pack enough for a full recovery course?

At 25 mg daily — one tablet per day — the 50-tablet pack covers exactly 50 days, spanning a standard 7-week concurrent SERM phase with a week of surplus. At 50 mg daily (two tablets), the pack covers 25 days, appropriate for the initial higher-dose phase before a step to 25 mg. For most enanthate-based cycles where mesterolone runs 6–7 weeks alongside a SERM, one pack is sufficient without a mid-course reorder. (2) angle_used

Manufacturer

API traceability — from certified synthesis source through to the finished 25 mg tablet — is the transparency dimension Nassa Labs has built into its Proviron product at the batch level. Mesterolone active pharmaceutical ingredient enters the facility accompanied by a vendor certificate of analysis that declares synthesis route, purity grade, heavy metal screen results, and residual solvent data referenced to ICH Q3C classification limits; incoming goods inspection verifies these declarations before any API quantity is released to the production floor. Finished tablets from each production run are then assigned to an individual lot number linked to two release-gate documents: an HPLC content-assay record confirming per-tablet mesterolone content against a certified reference standard, and an LAL endotoxin test certificate. Both documents must carry passing status before the lot is cleared for outbound movement. The resulting chain — supplier CoA through HPLC and LAL release records — means every pack of Nassa Labs Proviron 25mg/tab is traceable to its specific raw material intake event, a level of documentation continuity relevant to users who cross-reference product receipts against analytical data before incorporating any compound into a timed recovery protocol.